Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-1038-6, published online 17 August 2020.
In the version of this article initially published, the middle initial was missing from author name ‘Joshua Freedman’ (with Author contribution initials ‘J.F.’). The correct author name is ‘Joshua D. Freedman’, and the corresponding Author contribution initials are ‘J.D.F.’. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Laing, A.G., Lorenc, A., del Molino del Barrio, I. et al. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med 26, 1951 (2020). https://doi.org/10.1038/s41591-020-01186-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-01186-5
This article is cited by
-
Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort
Scientific Reports (2023)
-
Transcriptional differences between coronavirus disease 2019 and bacterial sepsis
Virology Journal (2022)
-
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Nature Communications (2022)
-
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Signal Transduction and Targeted Therapy (2021)
